Wound Management Technologies Responds to SEC Complaint
The SEC charged former Wound Management Technologies chairman, president & CEO Scott Haire of using kickbacks to “illegally generate stock sales.”
feature2
Ellenoff is Enthusiastic About the Power of Crowdfunding
Doug Ellenoff, a founding partner at Ellenoff Grossman & Schole, a New York-based law firm that focuses on securities law, has been very involved in understanding crowdfunding and the implications of the Job’s Act.
MRI Intervention’s Clearpoint Technology: The Future of MRI-Guided Surgery?
Siemens, BrainLab, and Boston Scientific have partnered with a company with the first FDA-approved technology that allows surgeons to see, in real-time, into a patient’s brain during any of the 2.2 million minimally-invasive neuro procedures that happen every year in the U.S.
OneMedForum NY 2012 to spotlight JOBS Act, Crowdfunding, and Promising Areas for Healthcare Investment
Key Emphasis: How to Profit from Disruptive Changes in Healthcare and Finance
Immunotherapy Trains the Immune System to Attack Cancer Cells
Immunotherapy is the new black when it comes to treating Cancer, raising hope in conquering this age old illness.
OneMedRadio: How Pluristem’s PLX Cells Saved a Dying Child
Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR) recently announced that a seven year-old girl suffering from an aplastic bone marrow whose condition was rapidly deteriorating is now experiencing a reversal of her condition.
Boston Scientific to Introduce Two New Devices at the New Cardiovascular Horizons Conference
The Massachusetts based company is a worldwide developer, manufacturer and marketer of medical devices.
Reed Smith partner, Gerry DiFiore Discusses Major Implications of Washington’s JOBS Act
Gerry DiFiore, partnered with the global law firm of Reed Smith is specialized in securities law on emerging growth companies. He recently co-authored a paper on the Jobs Act.
Four Cancer Therapies to Watch
On June 1, more than 25,000 cancer specialists will come together at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. With ASCO hours away, we look at some small biotech companies making headway in cancer treatment.
Biovest Seeking Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.